CoChat

Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome

Open access

The DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index, and 2 are not checked yet.

Abstract

Objective: Possibly due to a deficiency of insulin mediators, polycystic ovary syndrome (PCOS) is often associated with insulin resistance (IR) and hyperinsulinemia, likely responsible for an elevated production of reactive oxygen species. We investigated oxidative-related alterations in erythrocytes and anti-inflammatory effects of inositol in women with PCOS before and after treatment with myo-inositol (MYO). Methods: Twenty-six normal-weight PCOS patients were investigated before and after MYO administration (1200 mg/day for 12 weeks;n=18) or placebo (n=8) by evaluating serum testosterone, serum androstenedione, fasting serum insulin, fasting serum glucose, insulin area under the curve (AUC), and glucose AUC after oral glucose tolerance test and homeostasis model of assessment–IR. In erythrocytes, band 3 tyrosine phosphorylation (Tyr-P) level, glutathione (GSH) content, and glutathionylated proteins (GSSP) were also assessed. Results: Data show that PCOS patients' erythrocytes underwent oxidative stress as indicated by band 3 Tyr-P values, reduced cytosolic GSH content, and increased membrane protein glutathionylation. MYO treatment significantly improved metabolic and biochemical parameters. Significant reductions were found in IR and serum values of androstenedione and testosterone. A significant association between band 3 Tyr-P levels and insulin AUC was found at baseline but disappeared after MYO treatment, while a correlation between band 3 Tyr-P and testosterone levels was detected both before and after MYO treatment. Conclusions: PCOS patients suffer from a systemic inflammatory status that induces erythrocyte membrane alterations. Treatment with MYO is effective in reducing hormonal, metabolic, and oxidative abnormalities in PCOS patients by improving IR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/eje-11-0840

Cites

50 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 52 references

Research works printed but not linked: 4

  1. Gerli, 2003, European review for medical and pharmacological sciences, 7, 151
  2. 1994, 107, 99
  3. Carlomagno, 2011, European review for medical and pharmacological sciences, 15, 931
  4. 2008, METABOLISM CLINICAL AND EXPERIMENTAL, 10, 1390

Cited by

See all 89

Metadata

Authors
Donà, G., Sabbadin, C., Fiore, C., Bragadin, M., Giorgino, F. L., Ragazzi, E., Clari, G., Bordin, L., & Armanini, D.
Affiliations
  • University of Padua (IT)
  • Ca' Foscari University of Venice (IT)
Corresponding author
  • Bordin, Luciana
  • Armanini, Decio
Venue
European Journal of Endocrinology
Published
2012-04
Volume
166
Issue
4
Pages
703-710
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2135069653
Cited by
89
References
49
Citations by year
2026: 2 · 2025: 8 · 2024: 7 · 2023: 9 · 2022: 9 · 2021: 10 · 2020: 7 · 2019: 9 · 2018: 5 · 2017: 11 · 2016: 5 · 2015: 2 · 2014: 1 · 2013: 3 · 2012: 1
FWCI
2.61
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • ARCA (Università Ca' Foscari Venezia) (submittedVersion, other-oa)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Keywords
polycystic ovary syndrome, myo-inositol, oxidative stress, erythrocytes, insulin resistance, hyperinsulinemia, glutathione, glutathionylation, reactive oxygen species, testosterone, androstenedione, systemic inflammation
MeSH terms
Adult, Blood Glucose, Drug Administration Schedule, Erythrocyte Count, Erythrocytes, Female, Humans, Inositol, Insulin, Insulin Resistance, Placebos, Polycystic Ovary Syndrome, Down-Regulation, Oxidative Stress, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1530/eje-11-0840
The paper
Donà, G., Sabbadin, C., Fiore, C., Bragadin, M., Giorgino, F. L., Ragazzi, E., Clari, G., Bordin, L., & Armanini, D. (2012). Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome. European Journal of Endocrinology. https://doi.org/10.1530/eje-11-0840

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.